Cargando…

Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study

BACKGROUND: Individuals with glycogen storage disease IIIa (GSD IIIa) (OMIM #232400) experience muscle weakness and exercise limitation that worsen through adulthood. However, normative data for markers of physical capacity, such as strength and cardiovascular fitness, are limited. Furthermore, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennis, Philip J., Murphy, Elaine, Meijer, Rick I., Lachmann, Robin H., Ramachandran, Radha, Bordoli, Claire, Rayat, Gurinder, Tomlinson, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802498/
https://www.ncbi.nlm.nih.gov/pubmed/35101075
http://dx.doi.org/10.1186/s13023-022-02184-1
_version_ 1784642692924309504
author Hennis, Philip J.
Murphy, Elaine
Meijer, Rick I.
Lachmann, Robin H.
Ramachandran, Radha
Bordoli, Claire
Rayat, Gurinder
Tomlinson, David J.
author_facet Hennis, Philip J.
Murphy, Elaine
Meijer, Rick I.
Lachmann, Robin H.
Ramachandran, Radha
Bordoli, Claire
Rayat, Gurinder
Tomlinson, David J.
author_sort Hennis, Philip J.
collection PubMed
description BACKGROUND: Individuals with glycogen storage disease IIIa (GSD IIIa) (OMIM #232400) experience muscle weakness and exercise limitation that worsen through adulthood. However, normative data for markers of physical capacity, such as strength and cardiovascular fitness, are limited. Furthermore, the impact of the disease on muscle size and quality is unstudied in weight bearing skeletal muscle, a key predictor of physical function. We aim to produce normative reference values of aerobic capacity and strength in individuals with GSD IIIa, and to investigate the role of muscle size and quality on exercise impairment. RESULTS: Peak oxygen uptake (V̇O(2)peak) was lower in the individuals with GSD IIIa than predicted based on demographic data (17.0 (9.0) ml/kg/min, 53 (24)% of predicted, p = 0.001). Knee extension maximum voluntary contraction (MVC) was also substantially lower than age matched predicted values (MVC: 146 (116) Nm, 57% predicted, p = 0.045), though no difference was found in MVC relative to body mass (1.88 (2.74) Nm/kg, 61% of predicted, p = 0.263). There was a strong association between aerobic capacity and maximal leg strength (r = 0.920; p = 0.003). Substantial inter-individual variation was present, with a high physical capacity group that had normal leg strength (MVC), and relatively high V̇O(2)peak, and a low physical capacity that display impaired strength and substantially lower V̇O(2)peak. The higher physical capacity sub-group were younger, had larger Vastus Lateralis (VL) muscles, greater muscle quality, undertook more physical activity (PA), and reported higher health-related quality of life. CONCLUSIONS: V̇O(2)peak and knee extension strength are lower in individuals with GSD IIIa than predicted based on their demographic data. Patients with higher physical capacity have superior muscle size and structure characteristics and higher health-related quality of life, than those with lower physical capacity. This study provides normative values of these important markers of physical capacity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02184-1.
format Online
Article
Text
id pubmed-8802498
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88024982022-02-02 Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study Hennis, Philip J. Murphy, Elaine Meijer, Rick I. Lachmann, Robin H. Ramachandran, Radha Bordoli, Claire Rayat, Gurinder Tomlinson, David J. Orphanet J Rare Dis Research BACKGROUND: Individuals with glycogen storage disease IIIa (GSD IIIa) (OMIM #232400) experience muscle weakness and exercise limitation that worsen through adulthood. However, normative data for markers of physical capacity, such as strength and cardiovascular fitness, are limited. Furthermore, the impact of the disease on muscle size and quality is unstudied in weight bearing skeletal muscle, a key predictor of physical function. We aim to produce normative reference values of aerobic capacity and strength in individuals with GSD IIIa, and to investigate the role of muscle size and quality on exercise impairment. RESULTS: Peak oxygen uptake (V̇O(2)peak) was lower in the individuals with GSD IIIa than predicted based on demographic data (17.0 (9.0) ml/kg/min, 53 (24)% of predicted, p = 0.001). Knee extension maximum voluntary contraction (MVC) was also substantially lower than age matched predicted values (MVC: 146 (116) Nm, 57% predicted, p = 0.045), though no difference was found in MVC relative to body mass (1.88 (2.74) Nm/kg, 61% of predicted, p = 0.263). There was a strong association between aerobic capacity and maximal leg strength (r = 0.920; p = 0.003). Substantial inter-individual variation was present, with a high physical capacity group that had normal leg strength (MVC), and relatively high V̇O(2)peak, and a low physical capacity that display impaired strength and substantially lower V̇O(2)peak. The higher physical capacity sub-group were younger, had larger Vastus Lateralis (VL) muscles, greater muscle quality, undertook more physical activity (PA), and reported higher health-related quality of life. CONCLUSIONS: V̇O(2)peak and knee extension strength are lower in individuals with GSD IIIa than predicted based on their demographic data. Patients with higher physical capacity have superior muscle size and structure characteristics and higher health-related quality of life, than those with lower physical capacity. This study provides normative values of these important markers of physical capacity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02184-1. BioMed Central 2022-01-31 /pmc/articles/PMC8802498/ /pubmed/35101075 http://dx.doi.org/10.1186/s13023-022-02184-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hennis, Philip J.
Murphy, Elaine
Meijer, Rick I.
Lachmann, Robin H.
Ramachandran, Radha
Bordoli, Claire
Rayat, Gurinder
Tomlinson, David J.
Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
title Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
title_full Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
title_fullStr Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
title_full_unstemmed Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
title_short Aerobic capacity and skeletal muscle characteristics in glycogen storage disease IIIa: an observational study
title_sort aerobic capacity and skeletal muscle characteristics in glycogen storage disease iiia: an observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802498/
https://www.ncbi.nlm.nih.gov/pubmed/35101075
http://dx.doi.org/10.1186/s13023-022-02184-1
work_keys_str_mv AT hennisphilipj aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT murphyelaine aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT meijerricki aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT lachmannrobinh aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT ramachandranradha aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT bordoliclaire aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT rayatgurinder aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy
AT tomlinsondavidj aerobiccapacityandskeletalmusclecharacteristicsinglycogenstoragediseaseiiiaanobservationalstudy